“Diversity.” It’s a word that ... it now plays a central role in bridging the gap between research and clinical application. The importance of biosimilars only continues to grow, driven ...

The upcoming 15th Annual Outsourcing in Clinical Trials Europe conference will cover a wide range of topics on clinical ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Examining the implications of the recent US executive orders concerning diversity, equity, and inclusion pursuits—and the key ...

Discover how generative AI is revolutionising clinical trials, from enhancing patient recruitment to improving data analysis.

The following is a summary of “Community Leaders’ Perceptions of Pain and Research Engagement: Implications for Participant Diversity and Inclusion in Pain Clinical Trials,” published in the April ...

The research team noted that racial subgroups are underrepresented in clinical trials, a factor that should be addressed in ...

A new review finds federally qualified health centers (FQHCs) are underutilized in hypertension and type 2 diabetes clinical research, despite their potential to improve trial diversity.

LaShell Robinson, head of global feasibility and trial equity at Takeda, identifies some of the key barriers in achieving ...

In this video interview, Craig Lipset, co-chair, Decentralized Trials & Research Alliance (DTRA), discusses numerous themes that clin ops can focus on to keep its trials running efficiently and ...